CytRx Stock Quote
$0.31 -$0.07 0.0%
BATS BZX Real Time Price as of June 3, 2019, 4:30 p.m. EDT View Interactive CYTR Charts

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

News & Analysis: CytRx


Why CytRx Corporation Shares Jumped

CytRx shares jump after the Food and Drug Administration OKs an expansion of dosing options in an upcoming phase 3 trial for its key drug, aldoxorubicin.

Interactive Chart